Review Article

Split Viewer

Blood Res 2021; 56(S1):

Published online April 30, 2021

https://doi.org/10.5045/br.2021.2020332

© The Korean Society of Hematology

Molecular basis and diagnosis of thalassemia

Jee-Soo Lee, Sung Im Cho, Sung Sup Park, Moon-Woo Seong

Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

Correspondence to : Moon-Woo Seong, M.D., Ph.D.
Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
E-mail: mwseong@snu.ac.kr

Received: December 25, 2020; Revised: April 14, 2021; Accepted: April 16, 2021

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Thalassemia is characterized by the impaired synthesis of globin chains due to disease-causing variants in α- or β-globin genes. In this review, we provide an overview of the molecular basis underlying α- and β-thalassemia, and of the current technologies used to characterize these disease-causing variants for the diagnosis of thalassemia. Understanding these molecular basis and technologies will prove to be beneficial for the accurate diagnosis of thalassemia.

Keywords Thalassemia, α-globin gene, β-globin gene

Article

Review Article

Blood Res 2021; 56(S1): S39-S43

Published online April 30, 2021 https://doi.org/10.5045/br.2021.2020332

Copyright © The Korean Society of Hematology.

Molecular basis and diagnosis of thalassemia

Jee-Soo Lee, Sung Im Cho, Sung Sup Park, Moon-Woo Seong

Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

Correspondence to:Moon-Woo Seong, M.D., Ph.D.
Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
E-mail: mwseong@snu.ac.kr

Received: December 25, 2020; Revised: April 14, 2021; Accepted: April 16, 2021

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Thalassemia is characterized by the impaired synthesis of globin chains due to disease-causing variants in α- or β-globin genes. In this review, we provide an overview of the molecular basis underlying α- and β-thalassemia, and of the current technologies used to characterize these disease-causing variants for the diagnosis of thalassemia. Understanding these molecular basis and technologies will prove to be beneficial for the accurate diagnosis of thalassemia.

Keywords: Thalassemia, α-globin gene, β-globin gene

Fig 1.

Figure 1.The human α-globin gene cluster on chromosome 16 and the β-globin gene cluster on chromosome 11. The α-globin gene cluster contains three functional globin genes, the embryonic ζ gene (HBZ) and two fetal/adult α, α1 and α2, genes (HBA1 and HBA2) (A). The β-globin gene cluster contains five functional genes, the embryonic ε gene (HBE), two fetal Gγ and Aγ genes (HBG2 and HBG1), and adult δ and β (HBD and HBB) genes (B). HS-40 and the locus control region (LCR) regulate α- and β-globin gene expression, respectively. Hemoglobin differentially expressed at embryonic, fetal, and adult stages are represented (C).
Blood Research 2021; 56: S39-S43https://doi.org/10.5045/br.2021.2020332

Table 1 . Common variants of each variant type of α-thalassemia..

GeneVariant typeCommon variantEffect
α-globin gene--/--SEA, --MED, --FILα0
-α/3.7 and -α4.2α+
αTα/αIVS1(-5nt)α, αPA(AATAAG)α, αCSαα+
ααT/HBA1: c.223G>C (HbQ-Thailand)α+

Table 2 . Distribution of α-thalassemia genotypes identified in Seoul National University Hospital (South Korea)..

α-thalassemia genotypesN%
--SEA/αα833.3
α3.7/αα520.8
--SEA3.7416.7
α3.73.728.3
α3.7/α212 patchwork28.3
--/αα (ATRA-16 syndrome)14.2
αα/αα (HS-40 deletion)14.2
--SEA/-α4.214.2
Total24

Table 3 . Types of variants in β-thalassemia..

GeneVariant typeEffect
β-globin geneTranscriptional variantsβ+ or β++
Primary RNA transcript processingβ0, β+, or β++
3’ UTR or poly-A siteβ+
Translation
Initiation codonβ0
Premature termination codonβ0

Abbreviation: UTR, untranslated region..


Table 4 . Molecular spectrum of β-thalassemia identified in Seoul National University Hospital (South Korea)..

HGVS nomenclatureAmino acid changeN of alleles%
c.-138C>A10.6
c.-81A>G21.2
c.79G>Ap.Glu27Lys1811.0
c.92G>Ap.Arg31Lys10.6
c.92+1G>A21.2
c.92+1G>T21.2
c.92+2T>C10.6
c.92+5G>C31.8
c.93-21G>A31.8
c.93-1G>C21.2
c.315+1G>A127.4
c.316-197C>T10.6
c.316-2A>G10.6
c.1A>GStart loss21.2
c.2T>Gstart loss2515.3
c.48G>Ap.Trp16*63.7
c.52A>Tp.Lys18*1811.0
c.114G>Ap.Trp38*42.5
c.118C>Tp.Gln40*10.6
c.364G>Tp.Glu122*138.0
c.394C>Tp.Gln132*10.6
c.25_26delp.Lys9Valfs*1410.6
c.27dupp.Ser10Valfs*1484.9
c.126_129delp.Phe42Leufs*19159.2
c.201delp.Val68Cysfs*2210.6
c.217dupp.Ser72Lysfs*221.2
c.253_254delp.Thr85Leufs*610.6
c.270_271delp.Ser90Argfs*521.2
c.287dupp.Leu97Alafs*610.6
c.378_379delp.Val127Alafs*1310.6
c.182T>Ap.Val61Glu10.6
c.383A>Gp.Gln128Arg21.2
HBB whole gene deletion74.3
Beta-globin gene cluster deletion10.6
HBG2-HBB deletion10.6
Total163

Table 5 . Molecular diagnostic methods for thalassemia..

Mutation typeMethod
DeletionGap PCR
MLPAa,b)
Non-deletionAllele-specific PCR
Reverse dot blotting
Denaturing gradient gel electrophoresis
ARMS
Sanger sequencinga)
Next-generation sequencinga)

a)Methods currently applied in clinical laboratories in Korea. b)Commercial kits available [SALSA MLPA Probemix P140 and P102 (MRC-Holland, Amsterdam, The Netherlands)]..

Abbreviations: ARMS, amplification refractory mutation system; MLPA, multiplex ligation-dependent probe amplification; PCR, polymerase chain reaction..


Blood Res
Volume 59 2024

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download